Sarepta Therapeutics Inc
SWB:AB3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sarepta Therapeutics Inc
SWB:AB3A
|
US |
|
S
|
Sekisui House Ltd
XBER:SPH1
|
JP |
|
A
|
Aegon NV
XBER:AEND
|
NL |
|
T
|
Techo Hogar Socimi SL
MAD:YTCH
|
ES |
|
A
|
Agricultural Bank of China Ltd
XBER:EK7
|
CN |
|
Crescent Biopharma Inc
F:C68
|
US |
|
D
|
Deere & Co
DUS:DCO
|
US |
|
S
|
Scor SE
DUS:SDRC
|
FR |
|
Inpixon
NASDAQ:XTIA
|
US |
|
F
|
Fabrinet
F:FAN
|
KY |
|
T
|
TravelSky Technology Ltd
XMUN:TVL
|
CN |
|
A
|
Archos SA
F:AYH
|
FR |
|
Mitsubishi HC Capital Inc
OTC:MIUFF
|
JP |
|
Humana Inc
NYSE:HUM
|
US |
|
A
|
Akamai Technologies Inc
SWB:AK3
|
US |
|
D
|
Dover Corp
F:DOV
|
US |
|
Vulcan Energy Resources Ltd
F:VUL
|
AU |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
SWB:AIL
|
FR |
|
Franco-Nevada Corp
TSX:FNV
|
CA |
|
A
|
Anima Holding SpA
F:124
|
IT |
|
R
|
Rentokil Initial PLC
F:RTO1
|
UK |
|
B
|
Bilfinger SE
SWB:GBF
|
DE |
Wall St Price Targets
AB3A Price Targets Summary
Sarepta Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AB3A is 19.79 EUR with a low forecast of 4.38 EUR and a high forecast of 34.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AB3A's stock price target?
Price Target
19.79
EUR
According to Wall Street analysts, the average 1-year price target for AB3A is 19.79 EUR with a low forecast of 4.38 EUR and a high forecast of 34.61 EUR.
What is the Revenue forecast for Sarepta Therapeutics Inc?
Projected CAGR
-12%
Over the last 13 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 3 years is -12%.
What is the Gross Profit forecast for Sarepta Therapeutics Inc?
Projected CAGR
-8%
The compound annual growth rate for Gross Profit over the next 3 years is -8%.
